✦ LIBER ✦

CLinical Experience Acquired with Raptiva® (CLEAR) trial in patients with moderate-to-severe plaque psoriasis: results from extended treatment in an international, Phase III, placebo-controlled trial

✍ Scribed by Wolfram Sterry; Georg Stingl; Richard G.B. Langley; Hugh Zacharie; Morad Lahfa; Alberto Giannetti; Carlos Ferrándiz; Rodney Sinclair; Jean-Hilaire Saurat; the CLEAR Multinational Study Group

Book ID: 111274877
Publisher: John Wiley and Sons
Year: 2006
Tongue: German
Weight: 316 KB
Volume: 4
Category: Article
ISSN: 1610-0379
DOI: 10.1111/j.1610-0387.2006.06111.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

CLinical experience acquired with the ef

CLinical experience acquired with the efalizumab (Raptiva®) (CLEAR) trial in patients with moderate-to-severe plaque psoriasis: results from a phase III international randomized, placebo-controlled trial

✍ L. Dubertret; W. Sterry; J.D. Bos; S. Chimenti; S. Shumack; C.G. Larsen; N.H. Sh 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 342 KB

Ustekinumab treatment in patients with m

Ustekinumab treatment in patients with moderate to severe psoriasis who are nonresponders to etanercept: Results from a phase III clinical trial

📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 49 KB

Clinical Efficacy of Efalizumab in Patie

Clinical Efficacy of Efalizumab in Patients With Chronic Plaque Psoriasis: Results From Three Randomized Placebo-Controlled Phase III Trials: Part I

✍ David M. Pariser; Kenneth B. Gordon; Kim A. Papp; Craig L. Leonardi; Paul Kwon; 📂 Article 📅 2005 🏛 Springer-Verlag 🌐 English ⚖ 201 KB

The ustekinumab safety experience in pat

The ustekinumab safety experience in patients with moderate to severe psoriasis: Results from pooled analyses of phase II and phase III clinical trial data

📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 50 KB

Impact of efalizumab on patient-reported

Impact of efalizumab on patient-reported outcomes in patients with moderate to severe plaque psoriasis: pooled results from three randomized phase III trials

✍ Alan Menter; Tiffani Hamilton; Ivor Caro; Amy Chen-Rundle 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 58 KB

Efficacy and safety results from a phase

Efficacy and safety results from a phase III, randomized controlled trial comparing the safety and efficacy of briakinumab with etanercept and placebo in patients with moderate to severe chronic plaque psoriasis

✍ B.E. Strober; J.J. Crowley; P.S. Yamauchi; M. Olds; D.A. Williams 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 293 KB